Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Bionano Technology is a Chinese biotechnology company specializing in the development and commercialization of soluble microneedle patches for transdermal drug delivery. Utilizing a proprietary nanotechnology platform, the company creates painless delivery systems that penetrate the skin's stratum corneum to deliver active ingredients directly into the epidermis and dermis. Their business encompasses both the medical aesthetics market, where they offer commercialized products for skin repair and anti-aging, and the pharmaceutical sector, with a pipeline targeting vaccine delivery and chronic disease management. The company's technology is designed to improve drug stability, enhance patient compliance, and eliminate the need for traditional needle-and-syringe injections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Bionano Technology.